Bio-Techne (TECH) Earnings Analysis

Bio-Techne (TECH) has no confirmed upcoming earnings date. Last quarter (2026-02-04) it beat with EPS 0.46 USD vs 0.43 USD est (+7%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 101.10.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TECH next report earnings?

No confirmed upcoming earnings date is currently scheduled for TECH. This page updates as the calendar is published.

TECH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-040.46 USD0.43 USD+7%Beat
2025-02-050.42 USD0.3862 USD+8.8%Beat

Beat rate: 2/2 (100%) over reported quarters with consensus data.

TECH valuation and analyst view

Trailing P/E101.10
Trailing EPS0.70287 USD
Price / book5.37
Dividend yield0.45%
Market cap11.22B
Analyst consensusBuy (13 buy / 13 hold / 0 sell)
Avg price target63.11 USD

Related research pages

Frequently asked questions

When is Bio-Techne (TECH)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for TECH. This page updates as the calendar is published.

Did TECH beat earnings last quarter?

In its 2026-02-04 report, TECH posted EPS of 0.46 USD versus a 0.43 USD estimate — a beat of 7%.

What is TECH's earnings track record?

Over the last 2 reported quarters with consensus data, TECH beat estimates 2 times (100%).

What is TECH's current P/E ratio and EPS?

TECH trades at a trailing P/E of 101.10 on trailing EPS of 0.7028731245148916 USD.

What do analysts rate TECH?

Analyst consensus is "Buy" across 26 ratings (0 strong buy, 13 buy, 13 hold, 0 sell, 0 strong sell). Average 12-month price target: 63.11 USD.